Pfizer announced yesterday that it has begun an early stage clinical trial of an oral antiviral to fight COVID-19,
After initially rejecting Johnson & Johnson vaccines—saying they were “very good” but “not as good” as the Moderna and Pfizer’s—Detroit Mayor Mike Duggan walked back his statement,
Johnson & Johnson’s COVID-19 vaccine secured approvals for widespread use by the
It’s time to fix the staggering global inequities in access to COVID-19 vaccines, writes Gavin Yamey in a
Latin American governments are accusing Pfizer of “bullying” in COVID-19 vaccine negotiations—saying it is insisting upon extreme guarantees against future legal cases like using embassies and military bases as collateral. Protections for vaccine manufacturers in case of…
We’re not sure—but there are promising clues with new results expected in the coming weeks,
“This is like having gold.”
COVID-19 has revealed the extraordinary possibilities that can manifest when global scientific know-how is trained on a single topic. The virus was fully sequenced in January and a Phase 3 vaccine clinical trial is finishing in the fall.
“It feels amazing.” That's how one shipping staffer described sending out the first US COVID-19 vaccines yesterday from cargo hubs in Tennessee and Kentucky.
The US is poised to roll out millions of COVID-19 vaccine doses within days—with health workers and nursing home residents getting first dibs.